n.a. (ARIA)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Why Ariad Pharmaceuticals (ARIA) Is Up Today

Why Ariad Pharmaceuticals (ARIA) Is Up Today

Ariad Pharmaceuticals rises after a report says multiple industry majors have been circling the company since the FDA green-lit Ariad's Ponatinib, a leukemia treatment. The report cites rumors that three international pharma groups, including Eli Lilly, have made "friendly approaches" to Ariad and are prepared to offer as much as $20 a share to gain control. Other companies mentioned in the report include GlaxoSmithKline and Shire.

Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard

Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard

Ariad Pharmaceuticals was a leading decliner within the drugs industry, falling $0.30 (-4.3%) to $6.60 on light volume

5 Stocks Ready to Break Out

5 Stocks Ready to Break Out

These stocks are poised to break out and trade higher from current levels.

Ariad Pharmaceuticals (ARIA) Is Today's Pre-Market Mover With Heavy Volume Stock

Ariad Pharmaceuticals (ARIA) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a pre-market mover with heavy volume candidate

ARIAD Announces The Commercial Availability Of Iclusig (Ponatinib) For Patients With Refractory Philadelphia-Positive Leukemias In The U.S.

ARIAD Announces The Commercial Availability Of Iclusig (Ponatinib) For Patients With Refractory Philadelphia-Positive Leukemias In The U.S.

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the commercial availability of Iclusig ® (ponatinib) for adult patients with refractory chronic myeloid leukemia and Philadelphia-chromosome positive ...

J.P. Morgan Healthcare Confab Live Blog: Day Two

J.P. Morgan Healthcare Confab Live Blog: Day Two

TheStreet's Adam Feuerstein is providing live coverage from the most important healthcare investor conference of the year.

Today's Pre-Market Trading Very Positive For Ariad Pharmaceuticals (ARIA)

Today's Pre-Market Trading Very Positive For Ariad Pharmaceuticals (ARIA)

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a pre-market leader candidate

Biologics Selected By ARIAD To Be The Exclusive Specialty Pharmacy Provider For Iclusig (ponatinib)

Biologics Selected By ARIAD To Be The Exclusive Specialty Pharmacy Provider For Iclusig (ponatinib)

Biologics, Inc., an integrated oncology services company, is pleased to announce that it has been selected by ARIAD Pharmaceuticals, Inc.

Biotech Stock Mailbag: NeoStem, MannKind, Inovio

Biotech Stock Mailbag: NeoStem, MannKind, Inovio

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard

Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard

Ariad Pharmaceuticals was a leading decliner within the drugs industry, falling $0.10 (-1.5%) to $6.72 on light volume

A Strange Mix of Action

But it's exactly the trading environment I've been hoping for.

Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular

Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

3 Biotech Stocks Under $10 Triggering Breakouts

3 Biotech Stocks Under $10 Triggering Breakouts

Keep an eye on these under-$10 biotech stocks.

ARIAD To Present At The 32nd Annual J.P. Morgan Healthcare Conference

ARIAD To Present At The 32nd Annual J.P. Morgan Healthcare Conference

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the 32 nd Annual J.

Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard

Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard

Ariad Pharmaceuticals was a leading decliner within the drugs industry, falling $0.11 (-1.6%) to $7.00 on average volume

Heavy Volume And Pre-Market Movement For Ariad Pharmaceuticals (ARIA)

Heavy Volume And Pre-Market Movement For Ariad Pharmaceuticals (ARIA)

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a pre-market mover with heavy volume candidate

Ariad Pharmaceuticals Catches Fire

Ariad Pharmaceuticals Catches Fire

With a price target boost and the relaunching of its leukemia drug, this oncology company is soaring.

Why Ariad Pharmaceuticals (ARIA) is Soaring

Why Ariad Pharmaceuticals (ARIA) is Soaring

Ariad Pharmaceuticals (ARIA) saw double-digit percentage gains during Friday's trading session.

Ariad Pharmaceuticals (ARIA) Showing Unusual Social Activity Today

Ariad Pharmaceuticals (ARIA) Showing Unusual Social Activity Today

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as an unusual social activity candidate

ARIAD Pharmaceuticals, Inc., Based In Cambridge, MA (Photo: Business Wire)

ARIAD Pharmaceuticals, Inc., Based In Cambridge, MA (Photo: Business Wire)

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the U.

3 Hot Stocks to Trade (or Not)

3 Hot Stocks to Trade (or Not)

Here's a look at how to trade some of the most active stocks on the market today.

" alt="5 Stocks Under $10 Set to Soar" />

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to trade higher from current levels.

Trade-Ideas: Ariad Pharmaceuticals (ARIA) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Ariad Pharmaceuticals (ARIA) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a "perilous reversal" (up big yesterday but down big today) candidate

The Worst Biotech CEO of 2013 Is...

The Worst Biotech CEO of 2013 Is...

Vical's Vijay Samant is this year's CEO loser by a wide margin.

Your Vote Counts: Who Is the Worst Biotech CEO of 2013?

Your Vote Counts: Who Is the Worst Biotech CEO of 2013?

Amarin, Ariad, Vical, Dendreon and Aveo. You get to decide which CEO deserves to wear the badge of shame.

Ariad Pharmaceuticals (ARIA) Flagged As Today's Pre-Market Laggard

Ariad Pharmaceuticals (ARIA) Flagged As Today's Pre-Market Laggard

Trade-Ideas LLC identified Ariad Pharmaceuticals (ARIA) as a pre-market laggard candidate

ARIAD Announces Iclusig Data Presentations At Annual American Society Of Hematology Meeting

ARIAD Announces Iclusig Data Presentations At Annual American Society Of Hematology Meeting

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the schedule of several data presentations on Iclusig ® (ponatinib) that will take place at the 55th Annual Meeting of the American Society of ...

Ariad Pharmaceuticals (ARIA): Today's Featured Health Care Laggard

Ariad Pharmaceuticals (ARIA): Today's Featured Health Care Laggard

Ariad Pharmaceuticals was a leading decliner within the health care sector, falling $0.50 (-10.9%) to $4.07 on average volume

ARIAD Announces Iclusig Data Presentations At Annual American Society Of Hematology Meeting

ARIAD Announces Iclusig Data Presentations At Annual American Society Of Hematology Meeting

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the schedule of several data presentations on Iclusig ® (ponatinib) that will take place at the 55th Annual Meeting of the American Society of ...